Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Asarfi Hospital Ltd. IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 51  to  52 per share
Profile
Min Investment ₹52
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Asarfi Hospital Ltd is a leading healthcare institution dedicated to providing comprehensive medical services to the community. Located in an easily accessible area, the hospital is equipped with state-of-the-art facilities and a team of highly skilled healthcare professionals. With a commitment to excellence, Asarfi Hospital offers a wide range of medical specialties and services, including general medicine, surgery, pediatrics, obstetrics and gynecology, orthopedics, cardiology, and more. The hospital places a strong emphasis on patient care and ensures that all individuals receive personalized attention and compassionate treatment. Asarfi Hospital is known for its advanced diagnostic capabilities, modern operation theaters, and well-equipped intensive care units. By combining advanced medical technologies with a patient-centric approach, Asarfi Hospital Ltd strives to deliver the highest standards of healthcare to enhance the well-being and lives of its patients. Read More

Basic Info

Face Value 10 per share

Price 51  to  52 per share

P/E (x) 9.6

Sales( Cr.) 121

PAT( Cr.) 11

EPS 5.4

Draft Prospectus

Exchange BSE-SME

Promoter

Company Promoters

Harendra Singh Nayan Prakash Singh Udai Pratap Singh Madhuri Singh

Pre Issue Share Holding 83.03%

Post Issue Share Holding --%

Listing Details:

Listing Price: 98.8

Listing Gain: 47.37%

Current Price: 193.2

Gain On Issue: 193.2 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Jul 17, 2023
Closing Date Jul 19, 2023
Allotment Jul 20, 2023
Refund Jul 21, 2023
Delivery of Shares Jul 21, 2023
Listing Date Jul 24, 2023

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2000 104,000
Retail (Max) 1 2000 104,000
S-HNI (Min) 2 4000 208,000
S-HNI (Max) 9 18000 936,000
B-HNI (Min) 10 20000 1,040,000

Objective of the Issue

1. Part Funding of Capital Expenditure of Cancer Hospital at Ranguni, Jharkhand. 2. Acquiring Land on Leasehold basis for Health Management and Research Institute at Ranchi, Jharkhand. 3. General Corporate Purpose

Issue

Category Nos Bid Bid (x)
QIB 2590000 131054000 50.6x
NII 777000 350908740 451.6x
Retail 1813000 304239530 167.8x
EMP 0 0 0x
Total 5180000 1010825200 195.1x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Asarfi Hospital Ltd. Profit & Loss

#(Fig in Cr.) Mar 2024 Mar 2025 TTM
Net Sales 84 121
Other Income 2 8
Total Income 86 128
Total Expenditure 68 97
Operating Profit 18 31
Interest 3 4
Depreciation 9 13
Exceptional Income / Expenses 0 0
Profit Before Tax 6 14
Provision for Tax 2 4
Profit After Tax 4 11
Adjustments 0 0
Profit After Adjustments 4 11
Adjusted Earnings Per Share 2.1 5.4

Asarfi Hospital Ltd. Balance Sheet

#(Fig in Cr.) Mar 2024 Mar 2025
Shareholder's Funds 70 81
Minority's Interest 0 0
Borrowings 17 34
Other Non-Current Liabilities 22 8
Total Current Liabilities 44 41
Total Liabilities 154 164
Fixed Assets 94 102
Other Non-Current Assets 15 4
Total Current Assets 46 58
Total Assets 154 164

Asarfi Hospital Ltd. Cash Flow

#(Fig in Cr.) Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 1
Cash Flow from Operating Activities 26 -4
Cash Flow from Investing Activities -63 -7
Cash Flow from Financing Activities 36 13
Net Cash Inflow / Outflow -1 1
Closing Cash & Cash Equivalent 1 1

Asarfi Hospital Ltd. Ratios

# Mar 2024 Mar 2025
Earnings Per Share (Rs) 2.11 5.37
CEPS(Rs) 6.58 11.82
DPS(Rs) 0 0
Book NAV/Share(Rs) 35.78 41.16
Core EBITDA Margin(%) 19.03 19.53
EBIT Margin(%) 10.6 15.25
Pre Tax Margin(%) 7.39 11.87
PAT Margin (%) 4.93 8.77
Cash Profit Margin (%) 15.34 19.29
ROA(%) 2.7 6.65
ROE(%) 5.91 13.97
ROCE(%) 8.75 15.86
Receivable days 104.9 96.96
Inventory Days 7.78 6.17
Payable days 446.49 248.23
PER(x) 30.89 15.43
Price/Book(x) 1.83 2.01
Dividend Yield(%) 0 0
EV/Net Sales(x) 1.89 1.74
EV/Core EBITDA(x) 9.01 6.77
Net Sales Growth(%) 0 42.85
EBIT Growth(%) 0 105.54
PAT Growth(%) 0 154.14
EPS Growth(%) 0 154.14
Debt/Equity(x) 0.45 0.6
Current Ratio(x) 1.03 1.43
Quick Ratio(x) 0.99 1.37
Interest Cover(x) 3.31 4.51
Total Debt/Mcap(x) 0.25 0.3

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 44% 0% 0% 0%
Operating Profit CAGR 72% 0% 0% 0%
PAT CAGR 175% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 53% NA% NA% NA%
ROE Average 14% 10% 10% 10%
ROCE Average 16% 12% 12% 12%

Company Contact Information

Asarfi Hospital Ltd.

4th Floor, Asarfi Hospital Baramuri, Bishunpur Polytechnic

IPO Lead Manager(s)

Asarfi Hospital Ltd.

Hem Securities Ltd.

Registrar Info

Asarfi Hospital Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!